Derma Pella Facial Cleanser for Normal Skin

Manufacturer
Pella Pharmaceuticals Co. Ltd
Effective date
2024-12-31
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:50:20

Label at a glance#

ProductDerma Pella Facial Cleanser for Normal Skin
Active ingredientNIACINAMIDE
Label structure13 sections

Dosage and administration

- Use it twice a day, morning and evening. - Pump 2 - 3 times onto the tips of your fingers. - Massage gently over wet skin in a circular motion for 1 min, avoiding eye area. - Rinse thoroughly, pat skin dry. - Follow with a moisturizer.

Storage and handling

Store below 30 ◦ C

Label contents#

Full prescribing information#

Forms and Presentation

HOW SUPPLIED SECTION

Solution: Plastic Bottle, 150 ml

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Niacinamide (Vitamine B3)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Aqua, Glycerin, Cocamidopropyl Betain, Sodium C14-16 Olefin Sulfonate, Butylene Glycol, Polysorbate 20, Sodium Benzoate, Allantoin, Potassium Sorbate, Rosmarinus Officinalis (Rosemary) Leaf Extract, Disodium EDTA, Parfum, Citric Acid, Phenoxyethanol, 2-Bromo-2-Nitropropane-1,3-Diol, Tetrasodium EDTA, Benzoic Acid, Dehydroacetic Acid.

Purpose

OTC - PURPOSE SECTION

Facial Cleanser for Normal Skin

Properties

DESCRIPTION SECTION

This foaming face wash penetrates deep into your pores, scrubbing them from the inside out to eliminate dirt and oils.

Rosemary Extract makes the skin feel soft and sparkling by purifying, soothing, hydrating and provides anti-aging properties to the skin because it enriched in zinc, and vitamins A, B6, and C.

Niacinamide (Vitamin B3) helps soothe and balance the appearance of skin tone.

Allantoin which is an effective moisturizing ingredient used for it is gentle and non-irritating qualities.

Paraben free, Alcohol free, SLS free, SLES free.

Indications

INDICATIONS & USAGE SECTION

A mild facial cleanser for normal skin.

Precautions

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Warnings

WARNINGS SECTION

- For external use only.
- Avoid direct contact with eyes, if contact occurs, rinse thoroughly with water.

Contraindications

CONTRAINDICATIONS SECTION

Hypersensitivity to any of the components

Side Effects

ADVERSE REACTIONS SECTION

It is well tolerated product there is no known side effect.

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

- Use it twice a day, morning and evening.
- Pump 2 - 3 times onto the tips of your fingers.
- Massage gently over wet skin in a circular motion for 1 min, avoiding eye area.
- Rinse thoroughly, pat skin dry.
- Follow with a moisturizer.

Storage Conditions

STORAGE AND HANDLING SECTION

Store below 30 ◦C

Primary Package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Primary PackagePrimary Package

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82160-757-01Derma Pella Facial Cleanser for Normal Skin150 mL in 1 BOTTLE, PLASTICSOLUTION1502

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82160-757DERMA PELLA FACIAL CLEANSER FOR NORMAL SKIN (NIACINAMIDE) SOLUTION [PELLA PHARMACEUTICALS CO. LTD]21 package rows20250101_fe76096f-3853-05b8-e053-6294a90a5d60.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82160-75782160-757-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2a91378b-2a6a-125d-e063-6294a90a530afe76096f-3853-05b8-e053-6294a90a5d602024-12-31Warnings, Adverse reactionsExact identifier
spl id: 2a91378b-2a6a-125d-e063-6294a90a530a
spl set id: fe76096f-3853-05b8-e053-6294a90a5d60

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.